We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Martin Gleave MD, FRCSC, FACS

Martin E Gleave MD, FRCSC, FACS

Distinguished Professor, Univ. of British Columbia Director, Vancouver Prostate Centre, Vice Chair, Urologic Sciences, UBC, Vancouver, British Columbia, Canada

Dr. Gleave is a Distinguished Professor and Vice Chair of the Department of Urologic Sciences at the University of British Columbia (UBC), Director of the Vancouver Prostate Center, and a British Columbia Leadership Chair. 

Dr. Gleave’s research characterizes molecular mechanisms mediating treatment resistance in cancer, focusing on stress-activated adaptive responses that drive acquired treatment resistance, and designing rational combination co-targeting strategies to create conditional lethality and improve cancer control. 

Dr Gleave is the recipient of numerous awards, including the National Cancer Institute of Canada’s prestigious William Rawls Award for contributions to cancer control in Canada; the Barringer Medal from the American Association of GU Surgeons and the Eugene Fuller Award from the American Urological Association in 2013.